News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector
Thursday, May 04, 2023SHL Medical a worldleading provider of advanced drug delivery solutions announced that it has signed a collaboration agreement with MoonLake Immunotherapeutics a clinicalstage biotechnology company focused on creating nextlevel therapies for inflamma...
LenioBio GmbH Announces New CEO
Thursday, May 04, 2023LenioBio GmbH the Dsseldorfbased cellfree protein expression company has announced that its founder and CEO Dr Remberto Martis will be stepping down as CEO and has proudly named his successor as Andr Goerke starting June st Andre has previously held...
Lantern Pharma Develops Top-Ranked AI Algorithms to Predict the Blood-Brain-Barrier Permeability of Any Compound
Wednesday, May 03, 2023Lantern Pharma Inc a clinicalstage biopharmaceutical company using its proprietary RADR artificial intelligence AI and machine learning ML platform to transform the cost pace and timeline of oncology drug discovery and development today announced tha...
Tris Pharma Expands Leadership Team as Company Broadens Commercial Portfolio and Progresses Clinical Pipeline
Wednesday, May 03, 2023Tris Pharma Inc Tris a commercialstage biopharmaceutical company focused on ADHD pain and neurological disorders today announced the appointments of Thomas Englese as chief commercial officer and Marc Lesnick PhD as chief development officer We are t...
Bryn Pharma Expands Corporate Leadership with Three New Executive Hires and Additional Board Appointment
Wednesday, May 03, 2023Bryn Pharma LLC a privately held pharmaceutical company dedicated to finding a better way for patients and caregivers to treat anaphylaxis announced today the addition of three new executives to its leadership team Nurry Hong Chief Strategy and Busin...
Genmab To File Appeal in Its Second Arbitration Under License Agreement with Janssen
Tuesday, April 25, 2023Genmab AS announced today its decision to file a request for review of the award dismissing its claims in the second arbitration arising under its license agreement with Janssen Biotech Inc for daratumumab The review of the award will be conducted by...
Medigene AG presents final Phase I data of TCR-T cell therapy MDG1011 in patients with high-risk blood cancers
Tuesday, April 25, 2023Medigene AG an immunooncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors today reports final Phase I dose escalation results from firstinhuman Study of HLAArestricted PRAMEspecific T cell rec...
Genmab Announces Initial Resolution of Its Second Arbitration Under License Agreement with Janssen
Friday, April 21, 2023Genmab AS announced today an award in the second arbitration arising under its license agreement with Janssen Biotech Inc Janssen for daratumumab The arbitral tribunal dismissed Genmabs claims on the basis that they should have been brought in the fi...
Trinity Biotech Announces the $30 Million Sale of its Life Sciences Supply Business to Biosynth
Friday, April 21, 2023Trinity Biotech plc a leading developer and manufacturer of diagnostic solutions for the pointofcare and clinical laboratory markets today announced it has entered into an agreement to sell its Fitzgerald Industries life sciences supply business cons...
Oncotelic Therapeutics and Vectara Announce Strategic Partnership to Transform Pharmaceutical Research with Large Language Model Technology
Thursday, April 20, 2023Oncotelic Therapeutics Inc announced today a strategic partnership with Vectara a company specializing in innovative Natural Language Understanding NLU technologies to accelerate the development of novel therapies for the treatment of cancer infectio...
